Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B London

Showing results (241-250 of 310) with videos related to

Pageof 31
Sort By:
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastomaShahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
The Lancet. Oncology|July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trialSusan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Rochelle Bagatell, Susan L Cohn, et al.
JAMA|August 28, 2019
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical TrialJulie R Park, Susan G Kreissman, Wendy B London, et al.
JCO Global Oncology|December 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group ProjectWendy B London, Gabriela Villanueva, Derek Shyr, et al.
Blood|June 14, 2018
Normalizing hepcidin predicts <i>TMPRSS6</i> mutation status in patients with chronic iron deficiencyMatthew M Heeney, Dongjing Guo, Luigia De Falco, et al.
Radiology|May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group ProjectHervé J Brisse, M Beth McCarville, Claudio Granata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Clinicopathologic features and long-term outcomes of NUT midline carcinomaDaniel E Bauer, Chelsey M Mitchell, Kelly M Strait, et al.
Blood Advances|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosisBarbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Pageof 31

Showing results (241-250 of 310) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastomaShahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
The Lancet. Oncology|July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trialSusan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Rochelle Bagatell, Susan L Cohn, et al.
JAMA|August 28, 2019
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical TrialJulie R Park, Susan G Kreissman, Wendy B London, et al.
JCO Global Oncology|December 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group ProjectWendy B London, Gabriela Villanueva, Derek Shyr, et al.
Blood|June 14, 2018
Normalizing hepcidin predicts <i>TMPRSS6</i> mutation status in patients with chronic iron deficiencyMatthew M Heeney, Dongjing Guo, Luigia De Falco, et al.
Radiology|May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group ProjectHervé J Brisse, M Beth McCarville, Claudio Granata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Clinicopathologic features and long-term outcomes of NUT midline carcinomaDaniel E Bauer, Chelsey M Mitchell, Kelly M Strait, et al.
Blood Advances|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosisBarbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Pageof 31